Dietary capsaicin protects cardiometabolic organs from dysfunction

Nutrients

Volumn 8, Issue 5, 2016, Pages

  Sun, Fang ^a   Xiong, Shiqiang ^a   Zhu, Zhiming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Capsaicin; Chili pepper; Diabetes; Hypertension; Metabolic syndrome; Obesity; TRPV1

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CHOLECYSTOKININ; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; PEPTIDE YY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; VANILLOID RECEPTOR 1; TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ADIPOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CARDIOVASCULAR FUNCTION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; DYSLIPIDEMIA; FATTY LIVER; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; METABOLIC DISORDER; META ANALYSIS (TOPIC); NEOPLASM; NONHUMAN; OBESITY; OXIDATIVE STRESS; PAIN; PEPPER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; VASOCONSTRICTION; VASODILATATION; WEIGHT GAIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; PHYSIOLOGY;

CAPSAICIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; HUMANS; OBESITY; TRPV CATION CHANNELS;

EID: 85012822925     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8050174     Document Type: Review

References (89)

1. Galuppo, M.; Giacoppo, S.; Iori, R.; De Nicola, G.R.; Milardi, D.; Bramanti, P.; Mazzon, E. 4(alpha-l-rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that defends cerebral tissue and prevents severe damage induced by focal ischemia/reperfusion. J. Biol. Regul. Homeost. Agents 2015, 29, 343-356. [PubMed]
2. Toniato, E.; Spinas, E.; Saggini, A.; Kritas, S.K.; Caraffa, A.; Antinolfi, P.; Saggini, R.; Pandolfi, F.; Conti, P. Immunomodulatory effects of vitamin D on skin inflammation. J. Biol. Regul. Homeost. Agents 2015, 29, 563-567. [PubMed]
3. Baiomy, A.A.; Attia, H.F.; Soliman, M.M.; Makrum, O. Protective effect of ginger and zinc chloride mixture on the liver and kidney alterations induced by malathion toxicity. Int. J. Immunopathol. Pharmacol. 2015, 28, 122-128. [CrossRef] [PubMed]
4. Lu,W.; Zhang, R.; Zhu, J.; Xia, L.; Zhang, J. Oxymatrine and cancer therapy. Eur. J. Inflamm. 2015, 13, 148-153. [CrossRef]
5. Tapsell, L.C.; Hemphill, I.; Cobiac, L.; Patch, C.S.; Sullivan, D.R.; Fenech, M.; Roodenrys, S.; Keogh, J.B.; Clifton, P.M.; Williams, P.G.; et al. Health benefits of herbs and spices: The past, the present, the future. Med. J. Aust. 2006, 185, S4-S24. [PubMed]
6. Nilius, B.; Owsianik, G. Transient receptor potential channelopathies. Pflügers Arch. 2010, 460, 437-450. [CrossRef] [PubMed]
7. Nilius, B.; Owsianik, G.; Voets, T.; Peters, J.A. Transient receptor potential cation channels in disease. Physiol. Rev. 2007, 87, 165-217. [CrossRef] [PubMed]
8. Kawada, T.; Suzuki, T.; Takahashi, M.; Iwai, K. Gastrointestinal absorption and metabolism of capsaicin and dihydrocapsaicin in rats. Toxicol. Appl. Pharmacol. 1984, 72, 449-456. [CrossRef]
9. Matsumoto, K.; Kurosawa, E.; Terui, H.; Hosoya, T.; Tashima, K.; Murayama, T.; Priestley, J.V.; Horie, S. Localization of TRPV1 and contractile effect of capsaicin in mouse large intestine: High abundance and sensitivity in rectum and distal colon. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297, G348-G360. [CrossRef] [PubMed]
10. Zhu, Z.; Luo, Z.; Ma, S.; Liu, D. Trp channels and their implications in metabolic diseases. Pflügers Arch. 2011, 461, 211-223. [CrossRef] [PubMed]
11. Szallasi, A.; Cortright, D.N.; Blum, C.A.; Eid, S.R. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat. Rev. Drug Discov. 2007, 6, 357-372. [CrossRef] [PubMed]
12. Chen, J.; Li, L.; Li, Y.; Liang, X.; Sun, Q.; Yu, H.; Zhong, J.; Ni, Y.; Chen, J.; Zhao, Z. Activation of TRPV1 channel by dietary capsaicin improves visceral fat remodeling through connexin43-mediated Ca influx. Cardiovasc. Diabetol. 2015, 14, 1-14. [CrossRef] [PubMed]
13. Mózsik, G. Capsaicin as new orally applicable gastroprotective and therapeutic drug alone or in combination with nonsteroidal anti-inflammatory drugs in healthy human subjects and in patients. Prog. Drug Res. 2014, 68, 209-258. [PubMed]
14. Yang, D.; Luo, Z.; Ma, S.; Wong, W.T.; Ma, L.; Zhong, J.; He, H.; Zhao, Z.; Cao, T.; Yan, Z.; et al. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab. 2010, 12, 130-141. [CrossRef] [PubMed]
15. Li, J.; Wang, D.H. Increased gfr and renal excretory function by activation of TRPV1 in the isolated perfused kidney. Pharmacol. Res. 2008, 57, 239-246. [CrossRef] [PubMed]
16. Zhu, Y.; Wang, D.H. Segmental regulation of sodium and water excretion by TRPV1 activation in the kidney. J. Cardiovasc. Pharmacol. 2008, 51, 437-442. [CrossRef] [PubMed]
17. Whiting, S.; Derbyshire, E.; Tiwari, B.K. Capsaicinoids and capsinoids. A potential role for weight management? A systematic review of the evidence. Appetite 2012, 59, 341-348. [CrossRef] [PubMed]
18. Ludy, M.J.; Mattes, R.D. Comparison of sensory, physiological, personality, and cultural attributes in regular spicy food users and non-users. Appetite 2012, 58, 19-27. [CrossRef] [PubMed]
19. Wang, P.; Yan, Z.; Zhong, J.; Chen, J.; Ni, Y.; Li, L.; Ma, L.; Zhao, Z.; Liu, D.; Zhu, Z. Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis. Diabetes 2012, 61, 2155-2165. [CrossRef] [PubMed]
20. Gram, D.X.; Bo, A.; Istvan, N.; Olsen, U.B.; Brand, C.L.; Frank, S.; René, T.; Ove, S.; Carr, R.D.; Peter, S. Capsaicin-sensitive sensory fibers in the islets of langerhans contribute to defective insulin secretion in zucker diabetic rat, an animal model for some aspects of human type2 diabetes. Eur. J. Neurosci. 2007, 25, 213-223. [CrossRef] [PubMed]
21. Gram, D.X.; Hansen, A.J.; Deacon, C.F.; Brand, C.L.; Ribel, U.;Wilken, M.; Carr, R.D.; Svendsen, O.; Bo, A. Sensory nerve desensitization by resiniferatoxin improves glucose tolerance and increases insulin secretion in zucker diabetic fatty rats and is associated with reduced plasma activity of dipeptidyl peptidase iv. Eur. J. Pharmacol. 2005, 509, 211-217. [CrossRef] [PubMed]
22. De Jong, P.R.; Takahashi, N.; Harris, A.R.; Lee, J.; Bertin, S.; Jeffries, J.; Jung, M.; Duong, J.; Triano, A.I.; Lee, J.; et al. Ion channel TRPV1-dependent activation of ptp1b suppresses egfr-associated intestinal tumorigenesis. J. Clin. Investig. 2014, 124, 3793-3806. [CrossRef] [PubMed]
23. Ramos-Torres, A.; Bort, A.; Morell, C.; Rodriguez-Henche, N.; Diaz-Laviada, I. The pepper's natural ingredient capsaicin induces autophagy blockage in prostate cancer cells. Oncotarget 2015, 7, 1569-1583.
24. Anandakumar, P.; Kamaraj, S.; Jagan, S.; Ramakrishnan, G.; Asokkumar, S.; Naveenkumar, C.; Raghunandhakumar, S.; Vanitha, M.K.; Devaki, T. The anticancer role of capsaicin in experimentallyinduced lung carcinogenesis. J. Pharmacopunct. 2015, 18, 19-25. [CrossRef] [PubMed]
25. Yang, Z.H.; Wang, X.H.; Wang, H.P.; Hu, L.Q.; Zheng, X.M.; Li, S.W. Capsaicin mediates cell death in bladder cancer t24 cells through reactive oxygen species production and mitochondrial depolarization. Urology 2010, 75, 735-741. [CrossRef] [PubMed]
26. Touska, F.; Marsakova, L.; Teisinger, J.; Vlachova, V. A "cute" desensitization of TRPV1. Curr. Pharm. Biotechnol. 2011, 12, 122-129. [CrossRef] [PubMed]
27. Kang, J.H.; Kim, C.S.; Han, I.S.; Kawada, T.; Yu, R. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett. 2007, 581, 4389-4396. [CrossRef] [PubMed]
28. Zhang, L.L.; Yan Liu, D.; Ma, L.Q.; Luo, Z.D.; Cao, T.B.; Zhong, J.; Yan, Z.C.; Wang, L.J.; Zhao, Z.G.; Zhu, S.J.; et al. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Circ. Res. 2007, 100, 1063-1070. [CrossRef] [PubMed]
29. Sharma, S.K.; Vij, A.S.; Sharma, M. Mechanisms and clinical uses of capsaicin. Eur. J. Pharmacol. 2013, 720, 55-62. [CrossRef] [PubMed]
30. Joo, J.I.; Kim, D.H.; Choi, J.W.; Yun, J.W. Proteomic analysis for antiobesity potential of capsaicin on white adipose tissue in rats fed with a high fat diet. J. Proteome Res. 2010, 9, 2977-2987. [CrossRef] [PubMed]
31. Saito, M.; Yoneshiro, T.; Matsushita, M. Food ingredients as anti-obesity agents. Trends Endocrinol. Metab. 2015, 26, 585-587. [CrossRef] [PubMed]
32. Ono, K.; Tsukamoto-Yasui, M.; Hara-Kimura, Y.; Inoue, N.; Nogusa, Y.; Okabe, Y.; Nagashima, K.; Kato, F. Intragastric administration of capsiate, a transient receptor potential channel agonist, triggers thermogenic sympathetic responses. J. Appl. Physiol. 2011, 110, 789-798. [CrossRef] [PubMed]
33. Kawabata, F.; Inoue, N.; Masamoto, Y.; Matsumura, S.; Kimura,W.; Kadowaki, M.; Higashi, T.; Tominaga, M.; Inoue, K.; Fushiki, T. Non-pungent capsaicin analogs (capsinoids) increase metabolic rate and enhance thermogenesis via gastrointestinal TRPV1 in mice. Biosci. Biotechnol. Biochem. 2009, 73, 2690-2697. [CrossRef] [PubMed]
34. Wang, X.; Miyares, R.L.; Ahern, G.P. Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. J. Physiol. 2005, 564, 541-547. [CrossRef] [PubMed]
35. Akabori, H.; Yamamoto, H.; Tsuchihashi, H.; Mori, T.; Fujino, K.; Shimizu, T.; Endo, Y.; Tani, T. Transient receptor potential vanilloid 1 antagonist, capsazepine, improves survival in a rat hemorrhagic shock model. Ann. Surg. 2007, 245, 964-970. [CrossRef] [PubMed]
36. Choi, J.W.; Hwang, H.S.; Dong, H.K.; Joo, J.I.; Yun, J.W. Proteomic analysis of liver proteins in rats fed with a high-fat diet in response to capsaicin treatments. Biotechnol. Bioprocess Eng. 2010, 15, 534-544. [CrossRef]
37. Li, L.; Chen, J.; Ni, Y.; Feng, X.; Zhao, Z.; Wang, P.; Sun, J.; Yu, H.; Yan, Z.; Liu, D. TRPV1 activation prevents nonalcoholic fatty liver through ucp2 upregulation in mice. Pflügers Arch. 2012, 463, 727-732. [CrossRef] [PubMed]
38. Lee, G.R.; Shin, M.K.; Yoon, D.J.; Kim, A.R.; Yu, R.; Park, N.H.; Han, I.S. Topical application of capsaicin reduces visceral adipose fat by affecting adipokine levels in high-fat diet-induced obese mice. Obesity 2013, 21, 115-122. [CrossRef] [PubMed]
39. Kang, J.H.; Goto, T.; Han, I.S.; Kawada, T.; Kim, Y.M.; Yu, R. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Obesity 2010, 18, 780-787. [CrossRef] [PubMed]
40. Motter, A.L.; Ahern, G.P. TRPV1-null mice are protected from diet-induced obesity. FEBS Lett. 2008, 582, 2257-2262. [CrossRef] [PubMed]
41. Lee, E.; Jung, D.Y.; Kim, J.H.; Patel, P.R.; Hu, X.D.; Lee, Y.; Azuma, Y.; Wang, H.F.; Tsitsilianos, N.; Shafiq, U.; et al. Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance. FASEB J. 2015, 29, 3182-3192. [CrossRef] [PubMed]
42. Akiba, Y.; Kato, S.; Katsube, K.; Nakamura, M.; Takeuchi, K.; Ishii, H.; Hibi, T. Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet beta cells modulates insulin secretion in rats. Biochem. Biophys. Res. Commun. 2004, 321, 219-225. [CrossRef] [PubMed]
43. Kang, J.H.; Tsuyoshi, G.; Le Ngoc, H.; Kim, H.M.; Tu, T.H.; Noh, H.J.; Kim, C.S.; Choe, S.Y.; Kawada, T.; Yoo, H.; et al. Dietary capsaicin attenuates metabolic dysregulation in genetically obese diabetic mice. J. Med. Food 2011, 14, 310-315. [CrossRef] [PubMed]
44. Kwon, D.Y.; Kim, Y.S.; Shi, Y.R.; Cha, M.R.; Yon, G.H.; Yang, H.J.; Min, J.K.; Kang, S.; Park, S. Capsiate improves glucose metabolism by improving insulin sensitivity better than capsaicin in diabetic rats. J. Nutr. Biochem. 2013, 24, 1078-1085. [CrossRef] [PubMed]
45. Firth, A.L.; Remillard, C.V.; Yuan, X.J. Trp channels in hypertension. Biochim. Biophys. Acta 2007, 1772, 895-906. [CrossRef] [PubMed]
46. Thilo, F.; Loddenkemper, C.; Berg, E.; Zidek,W.; Tepel, M. Increased trpc3 expression in vascular endothelium of patients with malignant hypertension. Mod. Pathol. 2009, 22, 426-430. [CrossRef] [PubMed]
47. Liu, D.; Yang, D.; He, H.; Chen, X.; Cao, T.; Feng, X.; Ma, L.; Luo, Z.; Wang, L.; Yan, Z.; et al. Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats. Hypertension 2009, 53, 70-76. [CrossRef] [PubMed]
48. Deng, P.Y.; Li, Y.J. Calcitonin gene-related peptide and hypertension. Peptides 2005, 26, 1676-1685. [CrossRef] [PubMed]
49. Rocha, M.; Bendhack, L. Relaxation evoked by extracellular Ca2+ in rat aorta is nerve-independent and involves sarcoplasmic reticulum and l-type Ca2+channel. Vasc. Pharmacol. 2009, 50, 98-103. [CrossRef] [PubMed]
50. Wang, Y.; Wang, D.H. A novel mechanism contributing to development of dahl salt-sensitive hypertension: Role of the transient receptor potential vanilloid type 1. Hypertension 2006, 47, 609-614. [CrossRef] [PubMed]
51. Hao, X.; Chen, J.; Luo, Z.; He, H.; Yu, H.; Ma, L.; Ma, S.; Zhu, T.; Liu, D.; Zhu, Z. TRPV1 activation prevents high-salt diet-induced nocturnal hypertension in mice. Pflugers Arch. 2011, 461, 345-353. [CrossRef] [PubMed]
52. Li, L.; Wang, F.; Wei, X.; Liang, Y.; Cui, Y.; Gao, F.; Zhong, J.; Pu, Y.; Zhao, Y.; Yan, Z.; et al. Transient receptor potential vanilloid 1 activation by dietary capsaicin promotes urinary sodium excretion by inhibiting epithelial sodium channel alpha subunit-mediated sodium reabsorption. Hypertension 2014, 64, 397-404. [CrossRef] [PubMed]
53. Ruiz, C.; Gutknecht, S.; Delay, E.; Kinnamon, S. Detection of nacl and kcl in TRPV1 knockout mice. Chem. Senses 2006, 31, 813-820. [CrossRef] [PubMed]
54. Marshall, N.J.; Liang, L.; Bodkin, J.; Dessapt-Baradez, C.; Nandi, M.; Collot-Teixeira, S.; Smillie, S.J.; Lalgi, K.; Fernandes, E.S.; Gnudi, L.; et al. A role for TRPV1 in influencing the onset of cardiovascular disease in obesity. Hypertension 2013, 61, 246-252. [CrossRef] [PubMed]
55. Manjunatha, H.; Srinivasan, K. Hypolipidemic and antioxidant effects of curcumin and capsaicin in high-fat-fed rats. Can. J. Physiol. Pharmacol. 2007, 85, 588-596. [CrossRef] [PubMed]
56. Tani, Y.; Fujioka, T.; Sumioka, M.; Furuichi, Y.; Hamada, H.; Watanabe, T. Effects of capsinoid on serum and liver lipids in hyperlipidemic rats. J. Nutr. Sci. Vitaminol. 2004, 50, 351-355. [CrossRef] [PubMed]
57. Ma, L.; Zhong, J.; Zhao, Z.; Luo, Z.; Ma, S.; Sun, J.; He, H.; Zhu, T.; Liu, D.; Zhu, Z.; et al. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovasc. Res. 2011, 92, 504-513. [CrossRef] [PubMed]
58. Zhao, J.F.; Ching, L.C.; Kou, Y.R.; Lin, S.J.; Wei, J.; Shyue, S.K.; Lee, T.S. Activation of TRPV1 prevents oxldl-induced lipid accumulation and tnf-alpha-induced inflammation in macrophages: Role of liver x receptor alpha. Mediat. Inflamm. 2013, 2013, 925171.
59. Xiong, S.; Wang, P.; Ma, L.; Gao, P.; Gong, L.; Li, L.; Li, Q.; Sun, F.; Zhou, X.; He, H.; et al. Ameliorating endothelial mitochondrial dysfunction restores coronary function via transient receptor potential vanilloid 1-mediated protein kinase a/uncoupling protein 2 pathway. Hypertension 2016, 67, 451-460. [CrossRef] [PubMed]
60. Feng, G.; Yi, L.; Xiang, W.; Lu, Z.; Li, L.; Zhu, S.; Liu, D.; Yan, Z.; Zhu, Z. TRPV1 activation attenuates high-salt diet-induced cardiac hypertrophy and fibrosis through ppar-δ upregulation. PPAR Res. 2014, 2014, 491963.
61. Hongmei, L.; Qiang, L.; Hao, Y.; Peng, L.; Lu, Z.; Xiong, S.; Tao, Y.; Yu, Z.; Huang, X.; Peng, G. Activation of TRPV1 attenuates high salt induced cardiac hypertrophy through improvement of mitochondrial function. Br. J. Pharmacol. 2014, 172, 5548-5558.
62. Qiang, W.; Shuangtao, M.; De, L.; Yan, Z.; Bing, T.; Chenming, Q.; Yongjian, Y.; Dachun, Y. Dietary capsaicin ameliorates pressure overload-induced cardiac hypertrophy and fibrosis through the transient receptor potential vanilloid type 1. Am. J. Hypertens. 2014, 27, 1521-1529.
63. Xu, X.; Wang, P.; Zhao, Z.; Cao, T.; He, H.; Luo, Z.; Zhong, J.; Gao, F.; Zhu, Z.; Li, L.; et al. Activation of transient receptor potential vanilloid 1 by dietary capsaicin delays the onset of stroke in stroke-prone spontaneously hypertensive rats. Stroke 2011, 42, 3245-3251. [CrossRef] [PubMed]
64. Hind, W.H.; Tufarelli, C.; Neophytou, M.; Anderson, S.I.; England, T.J.; O'Sullivan, S.E. Endocannabinoids modulate human blood-brain barrier permeability in vitro. Br. J. Pharmacol. 2015, 172, 3015-3027. [CrossRef] [PubMed]
65. Sun, J.; Pu, Y.; Wang, P.; Chen, S.; Zhao, Y.; Liu, C.; Shang, Q.; Zhu, Z.; Liu, D. TRPV1-mediated ucp2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction. Cardiovasc. Diabetol. 2013, 12, 69. [CrossRef] [PubMed]
66. Zhang, Y.; Chen, Q.; Sun, Z.; Han, J.;Wang, L.; Zheng, L. Impaired capsaicin-induced relaxation in diabetic mesenteric arteries. J. Diabetes Complicat. 2015, 29, 747-754. [CrossRef] [PubMed]
67. Yu, J.H.; Kim, M.S. Molecular mechanisms of appetite regulation. Diabetes Metab. J. 2012, 36, 391-398. [CrossRef] [PubMed]
68. Scott, R.; Tan, T.; Bloom, S. Gut hormones and obesity: Physiology and therapies. Vitam. Horm. 2013, 91, 143-194. [PubMed]
69. Ahmad, Z.; Rasouli, M.; Azman, A.Z.; Omar, A.R. Evaluation of insulin expression and secretion in genetically engineered gut k and l-cells. BMC Biotechnol. 2012, 12, 64. [CrossRef] [PubMed]
70. Das, U.N. Obesity: Genes, brain, gut, and environment. Nutrition 2010, 26, 459-473. [CrossRef] [PubMed]
71. Leung, F.W. Capsaicin-sensitive intestinal mucosal afferent mechanism and body fat distribution. Life Sci. 2008, 83, 1-5. [CrossRef] [PubMed]
72. Ten Kulve, J.S.; Veltman, D.J.; van Bloemendaal, L.; Barkhof, F.; Deacon, C.F.; Holst, J.J.; Konrad, R.J.; Sloan, J.H.; Drent, M.L.; Diamant, M.; et al. Endogenous glp-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes. Diabetologia 2015, 58, 2688-2698. [CrossRef] [PubMed]
73. Smeets, A.J.; Westerterp-Plantenga, M.S. The acute effects of a lunch containing capsaicin on energy and substrate utilisation, hormones, and satiety. Eur. J. Nutr. 2009, 48, 229-234. [CrossRef] [PubMed]
74. Nakamura, T.; Onaga, T.; Kitazawa, T. Ghrelin stimulates gastric motility of the guinea pig through activation of a capsaicin-sensitive neural pathway: In vivo and in vitro functional studies. Neurogastroenterol. Motil. 2010, 4, 446-452. [CrossRef] [PubMed]
75. Szlachcic, A.; Sliwowski, Z.; Krzysiek-Maczka, G.; Majka, J.; Surmiak, M.; Pajdo, R.; Drozdowicz, D.; Konturek, S.J.; Brzozowski, T. New satiety hormone nesfatin-1 protects gastric mucosa against stress-induced injury: Mechanistic roles of prostaglandins, nitric oxide, sensory nerves and vanilloid receptors. Peptides 2013, 49, 9-20. [CrossRef] [PubMed]
76. Lv, J.; Qi, L.; Yu, C.; Yang, L.; Guo, Y.; Chen, Y.; Bian, Z.; Sun, D.; Du, J.; Ge, P.; et al. Consumption of spicy foods and total and cause specific mortality: Population based cohort study. BMJ 2015, 351, h3942. [CrossRef] [PubMed]
77. Leung, F.W. Capsaicin as an anti-obesity drug. Fortschritte Der Arzneimittelforschung.progress in Drug Research. Prog. Drug Res. 2014, 68, 171-179. [PubMed]
78. Wang, P.; Liu, D.; Zhu, Z. Transient receptor potential vanilloid type-1 channel in cardiometabolic protection. J. Korean Soc. Hypertens. 2011, 37-47. [CrossRef]
79. Yoshioka, M.; St-Pierre, S.; Drapeau, V.; Dionne, I.; Doucet, E.; Suzuki, M.; Tremblay, A. Effects of red pepper on appetite and energy intake. Br. J. Nutr. 1999, 82, 115-123. [PubMed]
80. Yoshioka, M.; St-Pierre, S.; Suzuki, M.; Tremblay, A. Effects of red pepper added to high-fat and high-carbohydrate meals on energy metabolism and substrate utilization in Japanese women. Br. J. Nutr. 1998, 80, 503-510. [PubMed]
81. Inoue, N.; Satoh, Y.M. Enhanced energy expenditure and fat oxidation in humans with high bmi scores by the ingestion of novel and non-pungent capsaicin analogues (capsinoids). Biosci. Biotechnol. Biochem. 2007, 71, 380-389. [CrossRef] [PubMed]
82. Ludy, M.J.; Moore, G.E.; Mattes, R.D. The effects of capsaicin and capsiate on energy balance: Critical review and meta-analyses of studies in humans. Chem. Senses 2012, 37, 103-121. [CrossRef] [PubMed]
83. Dömötör, A.; Szolcsányi, J.; Mózsik, G. Capsaicin and glucose absorption and utilization in healthy human subjects. Eur. J. Pharmacol. 2006, 534, 280-283. [CrossRef] [PubMed]
84. Kiani, J.; Sajedi, F.; Nasrollahi, S.A.; Esna-Ashari, F. A randomized clinical trial of efficacy and safety of the topical clonidine and capsaicin in the treatment of painful diabetic neuropathy. J. Res. Med. Sci. 2015, 20, 359-363. [PubMed]
85. Almaghrabi, S.Y.; Geraghty, D.P.; Ahuja, K.D.; Adams, M.J. Vanilloid-like agents inhibit aggregation of human platelets. Thromb. Res. 2014, 134, 412-417. [CrossRef] [PubMed]
86. Hogaboam, C.M.; Wallace, J.L. Inhibition of platelet aggregation by capsaicin. An effect unrelated to actions on sensory afferent neurons. Eur. J. Pharmacol. 1991, 202, 129-131. [CrossRef]
87. Fragasso, G.; Palloshi, A.; Piatti, P.M.; Monti, L.; Rossetti, E.; Setola, E.; Montano, C.; Bassanelli, G.; Calori, G.; Margonato, A. Nitric-oxide mediated effects of transdermal capsaicin patches on the ischemic threshold in patients with stable coronary disease. J. Cardiovasc. Pharmacol. 2004, 44, 340-347. [CrossRef] [PubMed]
88. Harada, N.; Okajima, K. Effects of capsaicin and isoflavone on blood pressure and serumlevels of insulin-like growth factor-i in normotensive and hypertensive volunteers with alopecia. Biosci. Biotechnol. Biochem. 2009, 73, 1456-1459. [CrossRef] [PubMed]
89. Ikuko, S.; Yasufumi, F.; Yusaku, I.; Naohiko, I.; Hitoshi, S.; Tatsuo,W.; Michio, T. Assessment of the biological similarity of three capsaicin analogs (capsinoids) found in non-pungent chili pepper (ch-19 sweet) fruits. Biosci. Biotechnol. Biochem. 2010, 74, 274-278.